Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post by ASCO, adding:
“Such a pleasure to join Hope Rugo of City of Hope on the ASCO Education By The Book Podcast to talk on rare cancer drug development- innovative trials, smarter strategies plus what’s next. Thanks for the thoughtful conversation and the spotlight on rare disease research.”
Quoting American Society of Clinical Oncology’s post:
“Hope Rugo of City of Hope and Vivek Subbiah of Sarah Cannon Docs
discuss innovative trial designs, treatment strategies, and key insights on the future of rare cancer research on the ASCO Education By the Book Podcast.”
More posts featuring Vivek Subbiah.